Medicus Pharma MDCXW Income Statement (2023-2026)

NASDAQ MDCXW
$0.33 -0.11 (-24.95%)
At close: Aug 11, 2026 · 4:00 PM EDT
Income Statement Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating items
Research & Development (Quarter) 0.32M1.28M2.01M1.44M8.72M-1.00M4.91M
Selling, General & Administrative (Quarter) 1.39M2.28M1.77M2.22M3.12M4.58M5.005.20M6.57M
Other Operating Expenses (Quarter) 0.56M1.37M-8.72M3.59M
Operating Expenses (Quarter) 1.71M3.55M2.33M3.59M5.13M6.02M15.007.79M11.48M
Operating Income (Quarter) -1.71M-3.55M-2.33M-3.59M-5.13M-6.02M-15.00-7.79M-11.48M
EBIT (Quarter) -1.71M-3.55M-2.33M-3.59M-5.13M-6.02M-15.00-7.79M-11.48M
Non-operating items
Interest & Investment Income (Quarter) 0.02M0.04M
Other Non Operating Income (Quarter) -0.08M0.06M0.02M-0.16M-0.55M-0.02M-0.21M
Net income details
EBT (Quarter) -1.71M-3.55M-2.37M-3.62M-5.43M-6.31M-0.26M-7.91M-11.68M
Profit After Tax (Quarter) -1.71M-3.63M-2.28M-3.54M-5.10M-6.18M-15.98M-3.24M-11.68M
Income from Non-Controlling Interests (Quarter) -77.00-225.00-0.07M
Income from Continuing Operations (Quarter) -1.71M-3.55M-2.37M-3.62M-5.43M-6.31M-0.26M-7.91M-11.68M
Consolidated Net Income (Quarter) -1.71M-3.55M-2.37M-3.62M-5.43M-6.31M-0.26M-7.91M-11.68M
Income towards Parent Company (Quarter) -1.71M-3.55M-2.37M-3.62M-5.43M-6.31M-0.26M-7.91M-11.68M
Net Income towards Common Stockholders (Quarter) -1.71M-3.55M-2.28M-3.54M-5.43M-6.31M-0.26M-15.07M-11.68M
Additional items
EPS (Basic) (Quarter) -0.21-0.44-0.24-0.37-0.44-0.44-0.01-0.87-0.68
EPS (Diluted) (Quarter) -0.21-0.44-0.24-0.37-0.44-0.44-0.01-0.87-0.68
Shares Outstanding (Quarter) 3.48M8.08M8.17M9.51M9.62M12.24M14.28M18.63M17.28M17.28M
Shares Outstanding (Diluted) (Quarter) 3.48M8.08M8.17M9.51M9.62M12.24M14.28M18.63M17.28M17.28M
Shares Outstanding (Entity) (Quarter) 3.48M8.08M8.17M10.85M9.62M13.42M15.94M20.97M17.28M60.17M
EBITDA (Quarter) -1.71M-3.55M-2.33M-3.59M-5.13M-6.02M-15.00-7.79M
Interest Expenses (Quarter) 2.150.04M0.04M0.33M0.29M0.26M0.12M